Highbridge Capital Management’s ASTEX PHARMACEUTICALS, INC COM ASTX Stock Holding History

Highbridge Capital Management’s Portfolio ASTX Stock Details ASTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	–	Sell	-80,602	Closed	-$685K	–	1590
2013 Q3	$685K	Sell	80,602 -329,158	-80%	-$2.08M	0.01%	784
2013 Q2	$1.68M	Buy	+409,760	New	+$2.2M	0.02%	529

Highbridge Capital Management's ASTX Position: Q4 2013 in Review

Highbridge Capital Management sold out of ASTEX PHARMACEUTICALS, INC COM (ASTX) in Q4 2013, closing a stake of 80,602 shares — an estimated $685K sold.

Highbridge Capital Management first reported a position in ASTX in Q2 2013 and held it in 2 quarters. The position peaked at $1.68M in Q2 2013. 0 funds tracked by Wall St. Rank hold ASTX as of Q4 2013.

Highbridge Capital Management reported no remaining ASTEX PHARMACEUTICALS, INC COM position as of Q4 2013 after selling out during the quarter.
Highbridge Capital Management sold 80,602 ASTEX PHARMACEUTICALS, INC COM shares in Q4 2013, an estimated $685K.
Highbridge Capital Management first reported a position in ASTEX PHARMACEUTICALS, INC COM in Q2 2013 and held it in 2 quarters.
Highbridge Capital Management's ASTEX PHARMACEUTICALS, INC COM position peaked at $1.68M in Q2 2013.
0 funds tracked by Wall St. Rank held ASTEX PHARMACEUTICALS, INC COM as of Q4 2013.

Based on Highbridge Capital Management's 13F filing for Q4 2013, filed 14 Feb 2014.